Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page now renders a 403 Forbidden error instead of the study record content, making the page inaccessible and preventing access to the trial details.SummaryDifference18%

- Check36 days agoChange DetectedThe page revision tag updated from v3.6.5 to v3.6.6, signaling a new version of the record. This reflects an update to the page without altering its substantive details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe revision tag changed from v3.6.4 to v3.6.5, indicating an internal update to the page template. This does not alter visible study details or user-facing content.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, signaling a new build/version. This appears to be a maintenance update that does not modify the study information or user-visible content.SummaryDifference0.1%

- Check93 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3, indicating a minor page update. The change does not affect study details, eligibility, outcomes, or user interaction.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing Revision: v3.6.0. This appears to be a minor site update that does not affect the study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.